Shares of Atai Life Sciences reached a new 52-week high of $7.26, according to recent market data.
The clinical-stage biopharmaceutical company achieved the milestone during the trading session, reflecting recent price movement in its equity.
Additional details regarding the catalysts behind the stock's movement were not immediately available from the market data.
